Variable | Non-EoGE (N = 236) | EoGE (N = 19) | P value* |
---|---|---|---|
Clinical features | |||
Male gender (%) | 142 (60.2) | 15 (78.9) | 0.105 |
Age, years | 10.2 (1–18 days) | 13.6 (5.4–17.4) | 0.022 |
Complications | 18 (7.6) | 3 (15.8) | 0.197 |
Bleeding | 13 (5.5) | 2 (10.5) | 0.309 |
Obstruction | 3 (1.3) | 1 (5.3) | 0.268 |
Perforation | 2 (0.8) | 0 | 1.000 |
Ulcer recurrence | 11 (4.7) | 4 (21.1) | 0.018 |
Allergic history | |||
Atopic dermatitis | 5 (2.1) | 5 (26.3) | < 0.001 |
Allergic rhinitis | 10 (7.2) | 2 (14.3) | 0.305 |
Asthma | 3 (2.2) | 0 | 1.000 |
Endoscopic findings n, (%) | |||
Gastric ulcer only | 67 (28.4) | 2 (10.5) | 0.092 |
Duodenal ulcer only | 144 (61.0) | 15 (78.9) | 0.121 |
Gastric and Duodenal ulcer | 25 (10.5) | 2 (10.5) | 1.000 |
Multiple ulcers | 69 (29.2) | 4 (21.1) | 0.448 |
Stomach nodularity | 36 (15.3) | 5 (26.3) | 0.202 |
Duodenal nodularity | 10 (4.2) | 0 | 1.000 |
Tissue eosinophils (count/HPF) n, (range) | |||
Upper esophagus | 0 (0–4) | 0 (0–103) | < 0.001 |
Lower esophagus | 0 (0–24) | 0 (0–100) | < 0.001 |
Stomach, antrum | 0 (0–20) | 5 (0–168) | < 0.001 |
Stomach, body | 0 (0–20) | 1 (0–55) | < 0.001 |
Duodenal bulb | 0 (0–18) | 35 (0–84) | < 0.001 |
Duodenal 2nd portion | 0 (0–42) | 25 (0–100) | < 0.001 |